Designing a multitarget In(III) compound to overcome the resistance of lung cancer cells to cisplatin.
Sign Up to like & getrecommendations! Published in 2023 at "Dalton transactions"
DOI: 10.1039/d2dt03374g
Abstract: Designing novel anticancer non-platinum metal agents is fully challenging. Herein, a series of little-known indium (In) 2-acetylpyridine thiosemicarbazone compounds as potential anticancer agents were designed, synthesized, and characterized. The hydrogen atoms at the N-4 position… read more here.
Keywords: iii compound; designing multitarget; multitarget iii; expression ... See more keywords